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Urolithiasis, the third most common disorder of the urinary tract is bundled with highly complex and unpredictably 
varied etiological factors. The undesirable adverse effects with current medications and the recurrence rate pose a major 
challenge in combating the disorder. Ravenala madagascariensis Sonn. has been used traditionally in treating kidney stone 
problems. The present study was aimed at investigating the antiurolithiatic activity of different extracts of the leaves of 
R. madagascariensis. Phytochemical screening carried out on the methanolic, hydromethanolic, and decoction extracts
revealed the presence of alkaloids, carbohydrates, glycosides, cardiac glycosides, steroids, proteins, flavonoids, and
quinones. Thin layer chromatography profiling of all three extracts was established. The turbidity method was carried out to
evaluate in-vitro antiurolithiatic activity and the herbal formulation cystone was used as the standard drug. The results of the
study showed that the decoction of R. madagascariensis exhibited excellent antiurolithiatic potential with an IC50 value of 
188.65 µg/mL in comparison with the methanolic (305.93 µg/mL) and hydromethanolic (306.83 µg/mL) extracts. Thus the 
findings of the study validate the claims of antiurolithiatic activity of R. madagascariensis that could be attributed to the 
presence of active phytoconstituents. Further studies are aimed at its formulation and development. 
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Introduction 
Urolithiasis is regarded as a multifactorial disease 
with complex and unpredictable ethiology
1
. Lithogenic 
factors include the patient’s age, gender, diet, fluid 
intake, climate, occupation, genetic and metabolic 
abnormalities
2
. Kidney stones are formed due to the 
crystallization of ions and macromolecules present in 
the supersaturated urine
3
. This involves a sequential 
process of supersaturation followed by nucleation, 
growth, and aggregation leading to the retention of 
particles on the urinary tract
4
. The prevalence of kidney 
stone disease ranges from 7-13% in North America, 
5-9% in Europe, and 1-5% in Asia
5
. In India, parts of 
Gujarat, Maharashtra, Punjab, Haryana and the states 
of the North East were remarked as the stone belts
6
. 
The crystalline components of kidney stones are mostly 
calcium oxalate and calcium phosphate crystals and to 
a lesser extent due to magnesium ammonium 
phosphate, uric acid, and cystine
7
. The current 
conventional treatments include medications and 
surgery using shock wave lithotripsy, ureteroscopic 
lithotripsy, digital endoscopy, and nephrolithotomy
8
. 
The major challenge in the treatment of urolithiasis is 
the recurrent renal stone formation
9,10
. Hence, an 
alternative approach from the natural origin in the 
treatment of kidney stones may pave way for further 
research in plants with promising antiurolithiatic 
claims. 
Ravenala madagascariensis Sonn., (family 
Strelitziaceae), an endemic species of Madagascar is 
also regarded as an iconic symbol of this island. 
Besides being renewable and inexpensive, the plant has 
been a source of income in local populations of 
Madagascar. Also, R.madagascariensis is widely 
cultivated in tropical and subtropical region and often 
planted in the gardens of South India
11
. The plant is a 
palm-like tree with rhizomatous roots, hard and woody 
stem with alternate distichously arranged leaves 
holding circinnate flowers. The fruits are oblong, 




R. madagascariensis Sonn., has been traditionally
used in the treatment of diabetes and kidney stone 
problems
13,14











. R. madagascariensis is regarded 
as a monospecific plant and based upon its 
morphological characteristics, habit and habitat, four 
varieties including Hirana, Bemavo, Horonorona and 
Menafalaka have been identified
16
. In an 
ethnobotanical study conducted by Rakotoarivelo  
et al., the ethnobotanical uses and economic value of 
all the four varieties in the local population of 
Ambalabe rural community were reported with varied 
usage as food, medicine and tools. Additionally, the 
study has further demanded suitable measures for long 




In our previous studies, we performed an in-vitro 
antidiabetic activity which showed the ethanolic and 
aqueous extracts as potent inhibitors of glucose 
diffusion. Further, the ethanolic and aqueous extracts 
were found to be effective antidiabetic, hypolipidemic, 




Further, in a study reported by Onifade et al., the 
ethanolic extract of R. madagascariensis was found to 
possess maximum antibacterial effect against Proteus 
vulgaris, Klebsiella pneumonia, Serratia marcescens, 
Citrobacter freundii and P. mirabilis. Additionally, 
the study has also reported the presence of tannins, 
phlobatannins, flavonoids, cardiac glycosides and 
anthraquinones and cyanogenic glycosides
21
. Also, 
toxicological studies carried out on different extracts 
of R. madagascariensis showed deleterious effects in 
the liver and heart of experimental rats which was 




Furthermore, a comparative study on the 
methanolic extracts of the pericarp, seed and aril of 
bemavo, a variety of R. madagascariensis fruits were 
reported to possess antimicrobial activity
23
. The study 
has also investigated the antioxidant activity of these 
extracts by DPPH assay and interestingly, the seed 
extract was found to be most active (about 12.9 fold) 
with an IC50 value of 0.57 µg/mL compared to the 
standard ascorbic acid (IC50 = 7.32 µg/mL). 
Also, a recent report on the anti-tumour effects of 
R. madagascariensis revealed a promising cytotoxic 
effect exhibited by the ethanolic extract in PANC-1 
and SW1990 pancreatic cell lines (IC50 value of 12.58 
µg/mL and 18.9 µg/mL respectively). Further, the 
HPTLC results recorded in the study revealed an 
enriched presence of phytoconstituents in n-hexane, 
ethyl acetate and ethanol extracts
24
.  
Moreover, the phytocompounds including  
β-sitosteryl-D-glucoside, (2E, 7R, 11R)-phytyl-3, 7, 
11, 15-tetramethylhexadec-2-enyl pentadecanoate, 





However, the folklore 
claims of this plant on kidney stones still remain 
unvalidated. Hence the present study focused on 
evaluating the anti-urolithiatic activity of various 
extracts of leaves of R. madagascariensis. 
 
Materials and Methods 
 
Chemicals and Reagents 
All the chemicals and reagents used in the study 
were procured from certified suppliers and were of 
the highest analytical grade. The polyherbal drug 
Cystone was purchased from The Himalaya Drug 
Company, Bengaluru. 
 
Collection and authentication of plant material 
Leaves of R. madagascariensis, were collected 
from Tambaram, Tamil Nadu in October 2019. The 
plant was identified and authenticated by Plant 
Anatomy Research Centre, Chennai, No. PARC/ 
2020/4281. The shade dried leaves were coarsely 
powdered and used for further studies. 
 
Extraction of plant material 
The methanolic and hydromethanolic extracts 
were prepared by macerating 300 g each of the 
powdered plant material with methanol (100%) and 
methanol-water (50-50%) at room temperature for 24 
h with occasional shaking. The extracts were then 
filtered and the filtrates were evaporated to dryness on 
a rotary evaporator under reduced pressure and stored 
in an airtight wide-mouthed bottle. A fresh decoction 
was prepared every time during the experiment by 
boiling 1 g of powdered plant material in 100 mL of 
distilled water for 5 minutes and evaporated to 
dryness
27
. The percentage yield was calculated using 
the formula, 
 
                            




where W2 is the weight of the extract and the 
bottle, W1 is the weight of the bottle alone, and W0 is 
the weight of the powdered plant sample subjected to 
extraction. 
 
Preliminary phytochemical analysis 
Preliminary phytochemical screening was carried 
out to identify the presence of various phytochemical 
constituents in all three extracts. The methanolic, 




hydromethanolic, and decoction extracts of  
R. madagascariensis leaves were subjected to 
phytochemical analysis using different chemical tests 
provided in the standard protocols for the presence of 
alkaloids, carbohydrates, glycosides, cardiac glycosides, 




Thin layer chromatography (TLC) profiling 
Thin layer chromatography was carried out using 
readymade silica gel G (Merck) precoated TLC plates. 
The extracts were diluted with respective solvents, 
spotted on the TLC plates, chromatographed using 
various mobile phases at different ratios by trial and 
error method. The methanolic extract and 
hydromethanolic extracts were run in the mobile phase, 
Ethylacetate:Toluene:Formic acid (7:3:1) and detected 
under UV light (365 nm). The solvent system,  
n-butanol:acetic acid:water (4:1:5) was used for the TLC 
of leaf decoction and the spots were detected in the 
presence of iodine vapour. Finally, Rf values were 




In-vitro antiurolithiatic activity10 
About 1 mL of 0.025 M calcium chloride 
dehydrate was mixed with 2 mL of Tris-buffer  
(pH 7.4) and 1 mL (10 mg/mL solution) of the 
extract. The reaction was completed by adding 1 mL 
of 0.025 M sodium oxalate to each test tube. The 
turbidity of the sample was measured using  
UV-Visible Spectrophotometer (Shimadzu, Japan) at 
620 nm after 10 minutes. The polyherbal formulation, 
cystone was used as the standard drug. The 
experiment was also carried out in the absence of an 
inhibitor (control). Each procedure was done in 
triplicates. The inhibition in the formation of a stone 
nucleus was calculated using the formula, 
 
                      
                                                          
      
 
Graphs were plotted with percentage inhibition at 
Y-axis and sample concentration at X-axis and the 




All data were presented as the mean±standard error 
mean (SEM). The experiments were repeated in 
triplicates. The groups were analysed by linear 
regression using Graphpad Prism 7 software. Any value 
of P <0.05 was considered statistically significant. 
 
Results and Discussion 
 
Preliminary Phytochemical analysis 
The percentage yield of the methanolic, 
hydromethanolic extracts and decoction of the powdered 
leaves of R. madagascariensis, was found to be 11.7% 
w/w, 8.2% w/w and 7.4% w/w respectively. The 
decoction showed the presence of carbohydrates, 
glycosides, proteins, flavonoids, saponins and quinones 
whereas both the methanolic and hydromethanolic 
extracts showed the presence of alkaloids, 
carbohydrates, glycosides, flavonoids, phenols, tannins, 
proteins, saponins and quinones (Table 1). These phyto-
constituents are of utmost significance in inhibiting 
urinary stone formation
29,30
. Saponins are known to 
disintegrate mucoproteins that are crucial components of 
stone matrix
31
. Also, tannins and polyphenols were 
found to inhibit calcium oxalate crystal formation as 
well as dissolve the preformed calcium oxalate crystals 
by aiding calcium complexation
32,33
. Therefore, the anti-
aggregatory activity would have been an outcome of 




Thin-layer chromatography profiling was 
performed to separate the presence of 
phytoconstituents in each extract. TLC plays a 
valuable role in the quality control of herbals, 
particularly, in drug authentication assuring its safety 
and purity
34-36
. Among various solvent systems used 
for the development of chromatogram at differing 
ratios, the mobile phase with the good resolution was 
Table 1 — The percentage yield and preliminary phytochemical screening of leaves of Ravenala madagascariensis Sonn. 
Extract Solvent used Physical nature Colour Yield (%w/w) Phytoconstituents 
Methanolic extract Methanol (100%) Semi-solid Dark brown 11.7%w/w Alkaloids, Carbohydrates, Glycosides, 





water (50% - 50%) 
Semi-solid Greenish brown 8.2%w/w Alkaloids, Carbohydrates, Glycosides, 
Flavonoids, Phenols, Tannins, Proteins, 
Saponins, Quinones 
Decoction Distilled water Semi-solid Light brown 7.4% w/w Carbohydrates, Glycosides, Proteins, 
Flavonoids, Saponins, Quinones 




used and Rf values were calculated (Table 2). Both the 
methanolic extract and hydromethanolic extract 
showed three (3) spots with Rf values 0.76, 0.83, 0.89 
in the solvent system, Ethylacetate:Toluene: Formic 
acid (7:3:1) of which two (2) spots were UV active. 
Leaf decoction showed three (3) spots with Rf values 
0.17, 0.38, 0.63 in the mobile phase system,  
n-butanol: acetic acid: water (4:1:5) in which iodine 
vapour was used as the detecting agent (Fig. 1). 
 
In-vitro Antiurolithiatic activity  
Urolithiasis stays as the third most common 
disorder of urinary tract, characterized by the 
sedimentation of poorly soluble crystalloids of 
supersaturated urine
37
. About 2% of the world 
population suffers from renal stone disease with a 





 decade of life
38
. In India, 
twelve per cent of the population is expected to have 
renal stones of which 50% of the cases may end up 
with kidney dysfunction
39
. In-vitro anti-urolithiatic 
activity of R. madagascariensis Sonn., leaf extracts 
were determined by turbidimetry method. The principle 
was based on the measurement of turbidity developed 
by the formation of calcium oxalate and their potential 
inhibition by the extracts of R. madagascariensis 
compared to the standard drug cystone. (Fig. 2) In the 
present study, all three extracts displayed dose-
dependent inhibition of calcium oxalate crystallisation. 
The maximum percentage inhibition effect was 
exhibited by decoction (92%) followed by the 
hydromethanolic extract (85%) and methanolic extract 
(82%) compared to the standard cystone (93%) at the 
maximum concentration of 1000 μg/mL. The IC50 
value of decoction of R. madagascariensis powdered 
leaves (188.65 μg/mL) showed the least and efficient 
IC50 value of 188.65 μg/mL than the methanolic 
(305.93 μg/mL), hydromethanolic (306.83 μg/mL) 
extracts and standard cystone (195.08 μg/mL). 
Supersaturation of urine results in calcium oxalate 
crystallization within the urinary tract. During 
nucleation, stone forming crystals unite to form 
clusters with the addition of new constituents
32
. In the 
present study, decoction of R. madagascariensis 
exhibited stronger antiurolithiatic activity than the 
methanolic and hydromethanolic extracts. The study 
reveals the nucleation preventing property of the 
decoction of R. madagascariensis and the results were 
comparable with standard cystone. An ethnomedicinal 
data collected by Bahmani et al., during the period of 
July-September 2012, reported 18 medicinal plants by 
Table 2  — TLC profile of various extracts of leaves of Ravenala madagascariensis Sonn. 
Extract Solvent system No. of spots Rf values Detecting agent 
Methanolic extract Ethylacetate:Toluene:Formic acid (7:3:1) 3 0.76, 0.83, 0.89 UV lamp 
Hydro-methanolic extract 3 0.76, 0.83, 0.89 




Fig. 1 — Thin layer chromatography of leaves of Ravenala 
madagascariensis Sonn. a) methanolic extract, b) hydromethanolic 




Fig. 2 — Percentage inhibition of stone nucleus formation of 
various extracts of leaves of Ravenala madagascariensis Sonn., 
by turbidimetry. Plot of percentage inhibition at various 
concentrations of methanolic, hydromethanolic and decoction 
extracts. Data are expressed as mean+SEM of triplicates.  
 




the traditional healers of Shiraz in the treatment of 
kidney stones. Interestingly, the study revealed the 
decoction to be the most frequently (68%) prescribed 
mode of preparation
40
. Further, a study by Vasanthi  
et al., has reported the antiurolithiatic potential of a 
popular South Indian traditional decoction, Sirupeelai 
Samoola Kudineer, practiced in Siddha system of 




Furthermore, in a similar study by Zarin et al., the 
antiurolithiatic ability of four different types of Musa 
species including, Musa acuminate x balbisiana Colla 
cv. ‘Awak Manis’, M. paradisiaca cv. Nangka, 
‘Pisang Nangka’, Musa acuminate Colla cv. ‘Sucrier’ 
and Musa acuminate x balbisiana Colla cv. ‘Awak 
Legor’ were investigated
43
. The results of the study 
revealed that the methanolic pseudo stem extracts of 
Musa acuminate x balbisiana Colla cv. ‘Awak Legor’ 
exhibited the highest percentage inhibition of calcium 
oxalate crystal nucleation of 55.39±1.01% at the end 
of 60min compared to standard cystone 
(30.87±0.74%). In our present study, we carried out a 
comparative antiurolithiatic activity in the methanolic, 
hydromethanolic and decoction of R. madagascariensis 
leaves and found that the decoction of  
R. madagascariensis to be highly active and showed a 
percentage inhibition of 92.09±0.15% compared to 
cystone (93.69±0.10%) at the concentration of 1000 
µg/mL. Moreover, the IC50 values were found to be 
305.93 µg/mL, 306.83 µg/mL, 188.65 µg/mL and 
195.08 µg/mL for methanolic extract, 




In the present work, preliminary phytochemical 
screening, TLC profiling, and antiurolithiatic activity 
of various extracts of leaves of R. madagascariensis 
were carried out. Preliminary phytochemical screening 
revealed the presence of various alkaloids, 
carbohydrates, glycosides, phenols, proteins, saponins, 
flavonoids, and quinones. TLC profiling established 
the presence of phytoconstitiuents in the respective 
extracts. The in-vitro antiurolithiatic activity was 
carried out and the decoction was found to possess the 
maximum efficacy with IC50 value of 188.65 μg/mL. 
The study strongly suggests that the leaf decoction 
could be an effective alternative approach against 
urolithiasis. Thus the current work can further pave 
way for formulation development, evaluation, and 
transformation into a potent nutraceutical. 
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